Pacific Biosciences of California, Inc. Restructuring and Related Cost, Number of Positions Eliminated
Pacific Biosciences of California, Inc. (PACB) reported Restructuring and Related Cost, Number of Positions Eliminated of 130 Person for the 1-month period ending 2011-09-30, per its 10-K filed 2013-03-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated · last filed 2013-03-15
- 2011-09-30: Restructuring and Related Cost, Number of Positions Eliminated 1 month 130.00 Person.
| Period end | Restructuring and Related Cost, Number of Positions Eliminated 1 month |
|---|---|
| 2011-09-30 | 130.00 Person 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |